These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
111 related articles for article (PubMed ID: 16968809)
1. Pharmacology and signaling properties of epidermal growth factor receptor isoforms studied by bioluminescence resonance energy transfer. Schiffer HH; Reding EC; Fuhs SR; Lu Q; Piu F; Wong S; Littler PL; Weiner DM; Keefe W; Tan PK; Nash NR; Knapp AE; Olsson R; Brann MR Mol Pharmacol; 2007 Feb; 71(2):508-18. PubMed ID: 16968809 [TBL] [Abstract][Full Text] [Related]
2. Monitoring interactions between receptor tyrosine kinases and their downstream effector proteins in living cells using bioluminescence resonance energy transfer. Tan PK; Wang J; Littler PL; Wong KK; Sweetnam TA; Keefe W; Nash NR; Reding EC; Piu F; Brann MR; Schiffer HH Mol Pharmacol; 2007 Dec; 72(6):1440-6. PubMed ID: 17715395 [TBL] [Abstract][Full Text] [Related]
3. Activation of the AKT and STAT3 pathways and prolonged survival by a mutant EGFR in human lung cancer cells. Akca H; Tani M; Hishida T; Matsumoto S; Yokota J Lung Cancer; 2006 Oct; 54(1):25-33. PubMed ID: 16872715 [TBL] [Abstract][Full Text] [Related]
4. Epidermal growth factor receptor regulates osteoclast differentiation and survival through cross-talking with RANK signaling. Yi T; Lee HL; Cha JH; Ko SI; Kim HJ; Shin HI; Woo KM; Ryoo HM; Kim GS; Baek JH J Cell Physiol; 2008 Nov; 217(2):409-22. PubMed ID: 18543257 [TBL] [Abstract][Full Text] [Related]
5. Monitoring the activation state of the insulin-like growth factor-1 receptor and its interaction with protein tyrosine phosphatase 1B using bioluminescence resonance energy transfer. Blanquart C; Boute N; Lacasa D; Issad T Mol Pharmacol; 2005 Sep; 68(3):885-94. PubMed ID: 15976035 [TBL] [Abstract][Full Text] [Related]
7. Targeting the EGFR and the PKB pathway in cancer. Klein S; Levitzki A Curr Opin Cell Biol; 2009 Apr; 21(2):185-93. PubMed ID: 19216065 [TBL] [Abstract][Full Text] [Related]
8. Differential gene expression analysis reveals generation of an autocrine loop by a mutant epidermal growth factor receptor in glioma cells. Ramnarain DB; Park S; Lee DY; Hatanpaa KJ; Scoggin SO; Otu H; Libermann TA; Raisanen JM; Ashfaq R; Wong ET; Wu J; Elliott R; Habib AA Cancer Res; 2006 Jan; 66(2):867-74. PubMed ID: 16424019 [TBL] [Abstract][Full Text] [Related]
9. Analysis of the epidermal growth factor receptor specific transcriptome: effect of receptor expression level and an activating mutation. Pedersen MW; Pedersen N; Damstrup L; Villingshøj M; Sønder SU; Rieneck K; Bovin LF; Spang-Thomsen M; Poulsen HS J Cell Biochem; 2005 Oct; 96(2):412-27. PubMed ID: 16075456 [TBL] [Abstract][Full Text] [Related]
10. Resistance to an irreversible epidermal growth factor receptor (EGFR) inhibitor in EGFR-mutant lung cancer reveals novel treatment strategies. Yu Z; Boggon TJ; Kobayashi S; Jin C; Ma PC; Dowlati A; Kern JA; Tenen DG; Halmos B Cancer Res; 2007 Nov; 67(21):10417-27. PubMed ID: 17974985 [TBL] [Abstract][Full Text] [Related]
11. Epidermal growth factor receptor activation in prostate cancer by three novel missense mutations. Cai CQ; Peng Y; Buckley MT; Wei J; Chen F; Liebes L; Gerald WL; Pincus MR; Osman I; Lee P Oncogene; 2008 May; 27(22):3201-10. PubMed ID: 18193092 [TBL] [Abstract][Full Text] [Related]
12. Fluorescence resonance energy transfer analysis of proapoptotic CD95-EGF receptor interactions in Huh7 cells. Eberle A; Reinehr R; Becker S; Häussinger D Hepatology; 2005 Feb; 41(2):315-26. PubMed ID: 15660394 [TBL] [Abstract][Full Text] [Related]
13. Mutations and response to epidermal growth factor receptor inhibitors. Laurent-Puig P; Lievre A; Blons H Clin Cancer Res; 2009 Feb; 15(4):1133-9. PubMed ID: 19228718 [TBL] [Abstract][Full Text] [Related]
14. Association with HSP90 inhibits Cbl-mediated down-regulation of mutant epidermal growth factor receptors. Yang S; Qu S; Perez-Tores M; Sawai A; Rosen N; Solit DB; Arteaga CL Cancer Res; 2006 Jul; 66(14):6990-7. PubMed ID: 16849543 [TBL] [Abstract][Full Text] [Related]
15. Monitoring the activation state of the insulin receptor using bioluminescence resonance energy transfer. Boute N; Pernet K; Issad T Mol Pharmacol; 2001 Oct; 60(4):640-5. PubMed ID: 11562424 [TBL] [Abstract][Full Text] [Related]
16. Interaction between the insulin receptor and Grb14: a dynamic study in living cells using BRET. Nouaille S; Blanquart C; Zilberfarb V; Boute N; Perdereau D; Burnol AF; Issad T Biochem Pharmacol; 2006 Nov; 72(11):1355-66. PubMed ID: 16934761 [TBL] [Abstract][Full Text] [Related]
17. Monitoring the activation state of insulin/insulin-like growth factor-1 hybrid receptors using bioluminescence resonance energy transfer. Blanquart C; Gonzalez-Yanes C; Issad T Mol Pharmacol; 2006 Nov; 70(5):1802-11. PubMed ID: 16926280 [TBL] [Abstract][Full Text] [Related]
18. Endogenous calmodulin interacts with the epidermal growth factor receptor in living cells. Li H; Ruano MJ; Villalobo A FEBS Lett; 2004 Feb; 559(1-3):175-80. PubMed ID: 14960328 [TBL] [Abstract][Full Text] [Related]
19. Quantitative image analysis of cellular protein translocation induced by magnetic microspheres: application to the EGF receptor. Brock R; Jovin TM Cytometry A; 2003 Mar; 52(1):1-11. PubMed ID: 12596246 [TBL] [Abstract][Full Text] [Related]
20. Reversible dimerization of EGFR revealed by single-molecule fluorescence imaging using quantum dots. Kawashima N; Nakayama K; Itoh K; Itoh T; Ishikawa M; Biju V Chemistry; 2010 Jan; 16(4):1186-92. PubMed ID: 20024999 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]